
IDEAS schedule for April 2025
Tuesday, April 1
CARLO ROVELLI: SEVEN BRIEF LESSONS ON PHYSICS
Think of some of the 20th Century science's most momentous developments — Einstein's theory of relativity, quantum physics, finding evidence of black holes. If you trace the chain of discoveries that led to these breakthroughs back far enough, you'll end up with the Italian astronomer, physicist and inventor, Galileo Galilei. Renowned Italian physicist Carlo Rovelli, author of best-selling books like Seven Brief Lessons on Physics, explains how Galileo's discoveries and insights revolutionized science and helped usher in modernity — and how we can still learn a lot from him today.
Wednesday, April 2
WALKING AMONG THE ANCIENTS: THE WABANAKI-ACADIAN OLD GROWTH FOREST
To walk in an old growth forest is to be stunned by its untouched beauty, its otherworldliness — soaring ancient trees above, rolling thick ground underfoot, and astounding biodiversity all around. (Scientists are even researching its compound-rich air, for a potential role in preventing and treating cancer.) The Wabanaki-Acadian Forest, which stretches from parts of the Maritimes and Southern Quebec down into several New England states, is comprised largely of newer forests, already cut down and logged, over and over. Just one per cent of its old growth is left, and the World Wildlife Fund lists it as endangered. On this episode, accompany IDEAS to a secret old growth forest stand in Nova Scotia, to learn of its many wonders. *This episode originally aired on June 11, 2024.
Thursday, April 3
PUTTING PRIDE ABOVE SHAME: LOVING YOUR COUNTRY IN THE 21st CENTURY (STEP THREE)
The first step to developing a healthy level of patriotism is to decide which country you in fact belong to. The second step is to understand what duties accompany that choice. Having taken those steps, a person can tackle what may be the toughest one, depending on the nationality in question: feeling proud. An ashamed patriot is theoretically possible, and to feel zero shame may be unhealthy as well as unlikely, but for countries to thrive and strive to be their best selves, their citizens must collectively find a sweet spot where positive feelings outweigh negative ones, just individuals need enough self-respect to overcome their inner demons. IDEAS producer Tom Howell gathers insights from Afghans, Israelis, and Americans in hopes of finding the key to doing patriotism right.
Friday, April 4
IDEAS FROM THE TRENCHES: THE CONSPIRACY PRACTICE
Growing up, PhD student Sarah believed in the literal interpretation of the Bible. Born into a devout evangelical Christian community, she fully espoused creationism and the historical existence of Noah's ark, and she predicted that non-believers faced a doom in hell upon Judgment Day. She's now estranged from her family, but draws on her evangelical past to understand the visceral belief people acquire in conspiracy theories — from PizzaGate to the 'stolen' 2020 US election. *This episode is part of our ongoing series, IDEAS from the Trenches. It originally aired on Sept. 21, 2022.
Monday, April 7
THE RADICAL POSSIBILITIES OF RETURN
What kinds of return are possible when you can't return home? Author of A History of Burning, novelist Janika Oza looks at the ways in which the narrative arcs of ordinary lives are shaped by ruptures like colonialism, war, and the Partition of India — and what it means to continually seek to return through stories, memories and objects. The Radical Possibilities of Return — the fourth in a series this season from Crow's Theatre in Toronto.
Tuesday, April 8
EXPOSING CRIME AND CORRUPTION IN THE WORLD: ICIJ DIRECTOR GERALD RYLE
It's estimated that a significant percentage of the world's wealth is held in secret offshore accounts — between $21 and $32 trillion. How much of the world's wealth is ferreted away is hard to know. However in the past decade billions of these hidden stashes have been uncovered through the thorough work of the International Consortium of Investigative Journalists (ICIJ). The ICIJ retains a network of more than 290 of the top investigative journalists around the work. Some of its major investigations include Offshore Leaks, Panama Papers, Paradise Papers, and Pandora Papers. These revealed the secrets of the rich and powerful and led to multiple arrests and official inquiries in more than 70 countries, and the resignations of the leaders of Pakistan, Iceland, and Malta. For the 2025 Dalton Camp Series, ICIJ Director Gerard Ryle is in conversation with IDEAS Host Nahlah Ayed.
Wednesday, April 9
RE-IMAGINING THE BORDER
A German, a Canadian, and an American walk onto the stage of the Centre Mont-Royal in Montréal, and try to agree on what's happening to the concept of a national border. They then set their imaginations to the task of picturing what borders should become, before the century is out. These conversants are Peter Altmaier, the German cabinet minister who ran his country's response to the 2015 "refugee crisis;" Julian Castro, U.S. secretary for housing under Barack Obama and current head of the U.S. Latino Community Foundation; and Ayelet Shachar, Canadian professor and author of The Shifting Border and The Birthright Lottery. IDEAS host Nahlah Ayed poses the questions.
Thursday, April 10
TBD
Friday, April 11
TB
Monday, April 14
TIMOTHY SNYDER ON FREEDOM
Historian Timothy Snyder (On Tyranny) speaks to Nahlah Ayed about his newest book, On Freedom. In a political era where the word freedom is defined and redefined by whichever faction needs to evoke it, Snyder argues that — more than the freedom from various things — we actually need the freedom to thrive, for the sake of our common future. Recorded in front of an audience at the Toronto Reference Library.
Tuesday, April 15
TBD
Wednesday, April 16
PROFESSORS' PATRIOTISM QUESTIONNAIRE
The intellectual class is reputed to feel squeamish about expressing patriotism. But time are a-changing. IDEAS producer Tom Howell attempts to pin down leading Canadian scholars on the extent to which their hearts swell with national pride, by subjecting each of them to a list of five questions aimed at both complicating and simplifying what they believe such professions of patriotism to mean.
Thursday, April 17
TBD
Please note: IDEAS will be preempted in some timezones for the 7 p.m. election debate.
Friday, April 18
AUTHOR BRETT POPPLEWELL ON SUPERAGING
Brett Popplewell chronicled the life of an octogenarian athlete for his 2024 Edna Staebler Award-winning book, Outsider. Dag Abaye rejects mainstream views of the aging body, and chooses to live alone in an old schoolbus in the mountains of B.C., challenging himself to run long distances each day. In this public talk, Brett Popplewell considers what he learned from his subject, and about pushing society's limits around aging.
IDEAS FOR A BETTER CANADA
We live in an era of eroding democracy where polarization is increasingly fracturing our sense of a shared reality. With another federal election approaching, there's a growing sense that our political system prioritizes short-term gains over the long-term health of our democracy. To address this, IDEAS hosted cross-Canada discussions to focus on local solutions with the potential to inspire national change. The series is part of CBC Collab fund and in partnership with the Samara Centre for Democracy.
Monday, April 21
IDEAS FOR A BETTER CANADA — PEI
In an ideal democracy, every citizen has a voice. Critics of Canada's first-past-the-post electoral system have long decried what they say is unfair representation in our halls of power. And for that and other reasons, voters are increasingly disengaged. As residents of Confederation's birthplace, Prince Edward Islanders have thought hard about the democratic exercise, engaging its citizens, and what can be done to reinvigorate our democracy. IDEAS host Nahlah Ayed hears from Prince Edward Islanders about how to can get the most out of our electoral system.
Tuesday, April 22
IDEAS FOR A BETTER CANADA — BURLINGTON
YOUR LIBRARY IS OPEN (AND BELIEVES IN DEMOCRACY)
Libraries are a target in the culture wars raging across the continent. Yet they exist to give everyone access to a wide variety of expressive content: even when those books, events, and materials may offend others. As upholders of the sometimes unpopular concept of intellectual freedom, can inclusive yet open library guidelines help remind us what democracy upholds? IDEAS host Nahlah Ayed visits Burlington Public Library in Ontario, to speak with local librarians, author Ira Wells (On Book Banning), and a community audience, about what can be learned from our libraries.
Wednesday, April 23
IDEAS FOR A BETTER CANADA — EDMONTON
WHY CAN'T WE BE FRIENDS?
In a politically polarized world, conversation across divides can go one of three ways: screaming from our silos, retreating into them, or patiently building bridges between them to allow for civil debate. From fostering deep empathy to role-playing games to re-defining community, we explore how to nurture healthier democracies by encouraging conversation. IDEAS host Nahlah Ayed hears from Edmontonians about how they make it work.
Thursday, April 24
IDEAS FOR A BETTER CANADA — NANAIMO
Housing affordability is reaching a crisis point across Canada. The affordability crisis brings debate to local communities, stokes conflict, between generations, and contributes to a crisis of homelessness. IDEAS host Nahlah Ayed visits Nanaimo, British Columbia to ask: What does it mean for society when owning or renting your own home is out of reach for so many? How do you build a community when it's so hard to find a home near work, schools, and social lives? What obligations does a society have to ensure safe and stable housing is accessible to everyone?
Friday, April 25
A HISTORY OF HUMAN SHIELDS
The use of human shields is likely as old as war itself. In contemporary times we often see the use of involuntary human shields in war and conflict by both regular armies and militias — a practice forbidden under international humanitarian law. But there is also a long history of people voluntarily putting their lives at risk as a way to protect and show solidarity with a person or ideal or to lay bare a difficult political or social reality. Depending on the circumstances, choosing to use one's own body as a form of protection might be celebrated or reviled. In this episode, we take a look at the history of human shields and how they've been used both as a weapon of war and a weapon of peace.
Monday, April 28
Tuesday, April 29
MARTHA BAILLIE ON GRIEF (WRITER'S TRUST)
The death of a family member can stir up both fond and bitter memories and a complicated stew of conflicting feelings — grief, loss, resentment, guilt, bewilderment, solace. In her memoir, There Is No Blue, acclaimed Canadian writer Martha Baillie probes the meanings and mysteries of death and family relationships through contemplations of three losses — her 99-year-old mother; her father; and her sister who suffered from schizophrenia and died by suicide shortly after her mother's death. There Is No Blue was the 2024 winner of the Hilary Weston Writers' Trust Award for Nonfiction.
Wednesday, April 30
SILENCE AND MEMORY: LILIA TOPOUZOVA
During the Communist era in Bulgaria there was little room for political dissent. Protesters or anyone who opposed the government could be arrested, sent to the Gulag, and silenced. For 20 years Lilia Topouzova has been collecting the stories of those who survived: some had many stories, some had little to say, some had nothing to say — or just no way of saying it. From these stories she has recreated a Bulgarian room from the Communist era, where her meetings and conversations with survivors can be heard, a space about the absence of memory and what that does to a people, a space to bear witness to those who were sent to the camps, but who were everyone's friends, relatives…neighbours. The installation 'The Neighbours' is the official Bulgarian entry to the 2024 Venice Biennale.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Winnipeg Free Press
2 days ago
- Winnipeg Free Press
The benefits of basic research in universities
Opinion A few weeks ago, I told my eldest son's wife that I planned to write and publish after retirement from the University of Winnipeg. She didn't understand, because she thought the job of university professors was just to teach. She did not appreciate that we do scientific research, including especially what might be called curiosity-driven or basic research with no foreseeable immediate application. Such misunderstanding appears widespread, given comments on right-wing Facebook pages. As U.S. President Donald Trump withholds government funding from Harvard and bans students from other countries, including Canada, comments appear like 'Cut funding to Harvard and give it to trades schools' and 'Harvard with $50 billion in endowment doesn't need taxpayer support.' Education in trades is important, but the money being cut is for research, not teaching, including basic research done in universities and without which people wouldn't even have a device or internet to spread misleading comments. Moreover, only interest from endowments can be spent, and just for purposes specified by donors (e.g., research, scholarships), not for general university operations. Spending only the interest ensures donors' goals last forever. Many people know Marie Curie discovered radioactivity, but fewer know her groundbreaking work was conducted at Sorbonne university in Paris. Government support for basic research on radioactivity by many university scientists led ultimately to MRI machines, nuclear power plants, and tools to support sustainable agriculture, to mention a few benefits. Another familiar scientist, Albert Einstein, is known for his highly theoretical research on relativity, developed in a Swiss patent office and then several universities. The theory seems far removed from practical use, but wrongly so. It is fundamental to many current devices, such as lasers and GPS, the latter using satellites with highly precise atomic clocks. Next time you use a smartphone to find your way, think of Einstein. Although Curie and Einstein are well known, much basic research leading to advances is carried out by unnamed scientists working away in university laboratories. Here are just a few examples of research that formed the foundation for applications we benefit from today. Lipid nanoparticles (LNPs) are tiny biological capsules (100-200 nanometers in size, 25.4 million nm = one inch), and studied for decades in universities, again with government funding. Better understanding of LNPs eventually led to such applications as delivering medicines to treat cancer or prevent disease and increasing uptake of nutrients in agriculture. Nanoparticles in catalytic converters reduce harmful emissions from cars. On the surface, pure mathematics appears an unlikely candidate for practical benefits. People studied number theory, for example, simply to understand the properties and beauty of mathematics. No one anticipated that the abstract and highly theoretical study of prime numbers divisible only by 1 and themselves (e.g., 3, 7, 53) would be fundamental for cryptography. Next time you make an e-transfer, thank number theory for the security of the transmission. Basic research in many sciences can lead to later applications. In cognitive psychology, for example, research on lists of words and other lab tasks demonstrated that mental images play an important role in memory. This theory informs applications in education, such as using multi-media to learn knowledge involving visual concepts as in chemistry. These examples illustrate that diverse applications depend on prior knowledge developed by research done out of curiosity without foreseen benefits. As noted by psychologist Kurt Lewin, 'There is nothing so practical as a good theory.' Applied research at universities is also undermined by cuts in taxpayer support. Governments funded years of work at the Universities of Manitoba and Saskatchewan that led to a variety of rapeseed plant with low acidic content and to one of Canada's largest crops and exports, canola. And many industries benefit from skilled graduates with research experience. How important is basic research? Very! J. H. Comroe Jr. and R. D. Dripps reviewed research necessary for certain medical advances (e.g., cardiac surgery, chemotherapy). Basic, curiosity-driven research made up about 40 per cent of studies, much done in universities. It makes sense. Without knowing how the heart works or cancer fundamentals, better diagnosis and treatment is impossible. I understand why my daughter-in-law did not appreciate the science side of my job. She never attended university and even if she had, few students see that part of university work unless they serve as research assistants or do research themselves, activities that are less likely with reduced taxpayer support. In short, research that lacks foreseeable applications is invisible to most members of the public. Sadly, short-sighted politicians can exploit people's lack of knowledge for political gain and to cut government support. The result is fewer countries invest in university research to simply understand the world, and fewer benefit economically from later applications without which the world is worse off. James M. Clark is a professor of Psychology at the University of Winnipeg.


The Market Online
21-05-2025
- The Market Online
Developing new therapies for traumatic central nervous system injuries
NurExone Biologic Inc. , an innovative biotech company pioneering exosome based therapies designed to help patients recover from traumatic central nerve system injuries. There's a lot happening at NurExone from the formation of a US subsidiary and a new CEO to lead that subsidiary to their plans for uplisting to a major US exchange and recent funding activity. Lyndsay Malchuk recently caught up with CEO, Shaltiel to an inside scoop on some exciting preclinical results and an upcoming scientific report that can mark a major step in the research development. The following is a transcription of the above video, and The Market Online has edited it for clarity . Lyndsay: I think the best place to actually start is with that US subsidiary. So tell us maybe a little bit about Exo-Top and can you tell us about the new Exo-Top CEO? Lior: Yes. So let's start with the context. We bought just recently in the end of last year, huge assets, which is the master cell bank in the US, a former US company. And these assets will stay in the US and this is the reason that we open the subsidiary there. The aim of the subsidiary is first of all to hold the master cell bank, develop it to a working cell bank and produce naive exosomes, which is the first step of our therapy for NurExone's supply, NurExone Ltd for further research and development for clinical phase. And because we are sitting on large assets, also offer exosomes in the highest standards as a B2B business for cosmetic, aesthetic and other vendors that would like to purchase it. Regarding the CEO, I'm very glad to have Jacob Licht on our Board. He came with more than 25 years of experience in a large pharmaceutical, including a lot of experience in operations and M&A. I think that bring NurExone to a new level. Speaking American and not just entrepreneurship Israelis. Lyndsay: Let's peel back just a little bit more here if we can. Now you've engaged with a number of North American investment banks in order to achieve that US exchange listing. So my question is, what can you share about that process, where it stands and what it means for NurExone's next phase of growth? Lior: Sure. So, we completed in April a $2.3 million Canadian dollar raise. We are well funded with the back wind of a very successful JP Morgan event in San Francisco. We got a lot of the attention from US and Canadian investment banks. And our plan is now to up list NurExone from Canada to a major stock exchange in the US in order to be in the right market. Because as you know, the majority of large pharmaceuticals that got into a clinic need to be on a major stock exchange with the support of the market and the liquidity. And we will get the support from these investment banks to raise in two steps pre IPO raise and after that a full IPO to a major stock exchange in the US. Lyndsay: How do you plan to use the funds to work and are you looking at any additional support from the government for grants in Israel? Lior: Yes, we are looking all the time non-governmental funds. We have interest from the Israeli defense ministry in order to apply NurExone products in the battlefield. I believe that it'll also be relevant for the US DOD, (Department of Defense). So non-governmental is of course one of the sources to support NurExone. But on top of that, as I said, we would like to use the raise now and the raise that we completed in April in order to proceed into a clinical stage company and provide all the necessary IND enabling study in order to submit it to the FDA. Lyndsay: I'm going to flip over here to go over some preclinical information that's exciting as well. So, the latest preclinical results around the ExoPTEN look really promising when it comes to improving motor function. So for you, what stood out in the findings? I mean, how does this move the needle for your research? Lior: That's a very good point. We changed models at NurExone, moving from a very, very severe and not physiological model, which is full transection the spinal cord, which we could see a motor sensoric and bladder functional recovery. But now we move to a more physiological in order to get more physiological data in a compression model, meaning that you're pressing the nerves and not cutting it. That's more of a fit to what happens to a human when you have an injury. And we see even stronger recovery. Okay. If you take a scale, the scale of motor recovery is even higher when you use the therapy. So this gives us a lot of hope that we are in the right direction. On top of that, we have also the results that we are getting more and more rats into the optic nerve damage showing the same strong recovery after just 18 days in an ERG. I think we are on the right track. We need to make sure that we have the whole package that the necessary for the FDA in order to translate our company to a clinical stage company. Lyndsay: Let's lean into that research further. I know that there's a scientific report that's coming out soon as well. So how big of a moment is that for you and what kind of response are you hoping for from regulators or investors or even potential partners? Lior: The correspondence with the FDA is critical. So one of the things that we want to keep is the dialogue. The last one that we had is in the end of 2023 when we completed the pre-IND. Since then we had a lot of progress. Our research became even more advanced, the production that we do in the 3D bioreactors is getting more advanced. So we have more questions today to the FDA and when sharing that we are getting ourself more focus, what is the right track? So, keeping the dialogue is critical and we are working with the regulator to help us bring the therapy further into a clinical stage. NurExone Biologic's website is and you can find them on the Venture Exchange under the ticker symbol NRX. Join the discussion: Find out what everybody's saying about this stock on the NurExone Biologic investor discussion forum, and check out the rest of Stockhouse's stock forums and message boards. The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here


Cision Canada
16-05-2025
- Cision Canada
MEXC Announces Einstein (EIN) Listing in July, 50 Million EIN Rewards Event Launches Now
VICTORIA, Seychelles, May 16, 2025 /CNW/ -- MEXC, a leading global cryptocurrency exchange, has announced that it will list Einstein (EIN) on July 20, 2025 (UTC). Ahead of the listing, MEXC will launch two exclusive events this May with a total reward pool of 50,000,000 EIN, offering users the opportunity to discover promising projects and earn attractive rewards. Einstein is an innovative social experiment combining scientific knowledge with the Web3 ecosystem. The project invites participants to explore the intersection of cryptocurrency, blockchain, decentralized science (DeSci), cosmology, and physics. By fostering a spirit of intellectual curiosity and discovery, Einstein aims to reveal the potential synergies between scientific inquiry and blockchain technology. The EIN token serves as the governance and fee token within the Einstein Protocol. It is utilized for synthesizing, upgrading, downgrading, and decomposing element tokens. All protocol fees are burned, giving EIN a deflationary utility. MEXC will launch two exclusive events from May 18, 10:00 to July 17, 10:00 (UTC), with the following key details: Event 1: Einstein (EIN) Launchpool - Stake USDT & MX to Share 42,500,000 EIN Users can stake USDT or MX tokens via MEXC Launchpool to earn EIN tokens. The staking mechanism is straightforward: the more users stake, the more they earn. In addition, users who stake MX tokens will also qualify for parallel participation in Kickstarter airdrop events, allowing users to earn double rewards. Event 2: Invite New Users & Share 7,500,000 EIN Users can earn 400 EIN for each friend who registers using their referral code, deposits a minimum of 100 USDT, and joins the Launchpool event. Each user can invite up to 20 new users for a maximum reward of 8,000 EIN. Rewards will be distributed on a first-come, first-served basis. MEXC has established itself as an industry leader by consistently providing users with early access to promising projects. According to the latest TokenInsight report, MEXC led the industry with an impressive 461 spot listings. During each bi-weekly period, MEXC maintained a high listing frequency, consistently ranking among the top six exchanges and demonstrating its ability to capture market trends quickly. To date, the exchange has listed more than 3,000 digital assets. MEXC will continue to maintain its industry-leading listing efficiency, innovate, and expand its offerings, ensuring users have access to the best opportunities in the ever-evolving crypto landscape. For full event details and participation rules, please visit here. About MEXC Founded in 2018, MEXC is committed to being "Your Easiest Way to Crypto." Serving over 40 million users across 170+ countries, MEXC is known for its broad selection of trending tokens, everyday airdrop opportunities, and low trading fees. Our user-friendly platform is designed to support both new traders and experienced investors, offering secure and efficient access to digital assets. MEXC prioritizes simplicity and innovation, making crypto trading more accessible and rewarding. The information provided in this article regarding cryptocurrencies does not constitute investment advice. Given the highly volatile nature of the cryptocurrency market, investors are encouraged to carefully assess market fluctuations, the fundamentals of projects, and potential financial risks before making any trading decisions.